These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2672494)

  • 1. [Postmenopausal estrogen therapy. Recent aspects of parenteral administration of 17-beta estradiol].
    Andersen HJ; Andreasen E; Jensen HK
    Ugeskr Laeger; 1989 Aug; 151(32):2006-9. PubMed ID: 2672494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaginal estradiol and progesterone in climacteric therapy].
    Pedersen OD; Jensen HK
    Ugeskr Laeger; 1989 Aug; 151(32):2016-9. PubMed ID: 2672496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.
    Godsland IF; Manassiev NA; Felton CV; Proudler AJ; Crook D; Whitehead MI; Stevenson JC
    Clin Endocrinol (Oxf); 2004 May; 60(5):541-9. PubMed ID: 15104556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of percutaneous absorption of estradiol and progesterone in absolute alcohol in postmenopausal women].
    Madsen LG; Munck AM; Pedersen OD; Micic S; Nielsen J; Svenstrup B; Jensen HK
    Ugeskr Laeger; 1989 Aug; 151(32):2026-30. PubMed ID: 2773122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin contamination by oestradiol gel--a remarkable source of error in plasma oestradiol measurements during percutaneous hormone replacement therapy.
    Vihtamäki T; Luukkaala T; Tuimala R
    Maturitas; 2004 Aug; 48(4):347-53. PubMed ID: 15283926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17 beta.
    Lyrenäs S; Carlström K; Bäckström T; von Schoultz B
    Br J Obstet Gynaecol; 1981 Feb; 88(2):181-7. PubMed ID: 7459307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous estrogen therapy in the post-menopausal period].
    Keller PJ
    Schweiz Med Wochenschr; 1989 Jul; 119(29):999-1004. PubMed ID: 2678438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contraception in the hypertensive woman using a vaginal ring delivering estradiol and norgestrel].
    Elkik F; Basdevant A; Corvol P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1737-9. PubMed ID: 3938250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
    Bunyavejchevin S; Limpaphayom KK
    J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension.
    Spritzer PM; Vitola D; Vilodre LC; Wender MC; Reis FM; Ruschel S; Castro I
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):267-73. PubMed ID: 12951632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
    Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
    Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oestrone-releasing vaginal ring in the treatment of climacteric women.
    Sipinen S; Lähteenmäki P; Luukkainen T
    Maturitas; 1980 Dec; 2(4):291-9. PubMed ID: 7231201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.